Doxosal
Doxosal Products are primarily used for
About Doxosal Products
Uses of Doxosal Products
Doxofylline is used in the treatment and prevention of chronic obstructive pulmonary disease and asthma.
Doxosal Products side effects
Common
Side Effects of Doxosal are Headache, Nausea1a, Vomiting, Insomnia (difficulty in sleeping), Epigastric pain, Irritability, Tachycardia.
How Doxosal Products work
Doxofylline is a bronchodilator. It works by relaxing the muscles of the airways and widens airways. This makes breathing easier.
Patient Concerns about Doxosal Products
Frequently asked questions about Doxosal Products
Frequently asked questions about Doxofylline
Q. What is Doxosal 400 Tablet?
Doxosal 400 Tablet is a new generation long-acting oral bronchodilator. It is a methyxanthine derivative.
Q. How does Doxosal 400 Tablet work?
Doxosal 400 Tablet inhibits an enzyme called phosphodiesterase which results in bronchodilation (dilation or widening of the airways in the lungs by relaxing the surrounding smooth muscle). It is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). COPD is a lung disease characterized by chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible. Doxosal 400 Tablet relieves the breathlessness and cough thereby providing symptomatic relief.
Q. Is Doxosal 400 Tablet antibiotic?
Doxosal 400 Tablet is not an antibiotic. Doxosal 400 Tablet is a bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Q. Is Doxosal 400 Tablet a steroid?
Doxosal 400 Tablet is not a steroid. Doxosal 400 Tablet is a bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Q. What is Doxosal 400 Tablet used for?
Doxosal 400 Tablet is a bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It helps to relieve breathlessness and cough thereby providing symptomatic relief.
Products for Doxosal
₹72
8% off
MRP
₹78
Not Available